Fungal endocarditis accounts for 1% to 3% of all infective endocarditis cases, is associated
with high morbidity and mortality (> 70%), and presents numerous challenges during clinical …

Mucormycosis is a difficult to diagnose rare disease with high morbidity and mortality.
Diagnosis is often delayed, and disease tends to progress rapidly. Urgent surgical and …

Objectives To describe the epidemiology, management and outcome of individuals with
mucormycosis; and to evaluate the risk factors associated with mortality. Methods We …

Uncommon, or rare, yeast infections are on the rise given increasing numbers of patients
who are immunocompromised or seriously ill. The major pathogens include those of the …

Invasive aspergillosis (IA) in haematology/oncology patients presents as primary infection or
breakthrough infection, which can become refractory to antifungal treatment and has a high …

Understanding of the taxonomy and phylogeny of Cryptococcus gattii has been advanced by
modern molecular techniques. C. gattii probably diverged from Cryptococcus neoformans …

Nearly 40 years have elapsed since the invention of the PCR, with its extremely sensitive
and specific ability to detect nucleic acids via in vitro enzyme-mediated amplification. In turn …

Fungal infections are becoming more frequent because of expansion of at-risk populations
and the use of treatment modalities that permit longer survival of these patients. Because …

Mycoses summarized in the hyalohyphomycosis group are heterogeneous, defined by the
presence of hyaline (non‐dematiaceous) hyphae. The number of organisms implicated in …

Invasive fungal diseases (IFDs) present an increasing global burden in
immunocompromised and other seriously ill populations, including those caused by …